RE: CEO /Securing Funding Article13 Apr 2022 13:38
Since then, the company has revealed that it has managed to secure £11.35million in funding, which is made up of “£6.35million of loan notes and an additional £5million of loan notes to be drawn down by mutual consent”. The funding is part of a note purchase agreement with Gatemore Capital Management LLP, Lansdowne Partners LLP, Sand Grove Capital Management LLP and Peel Hunt LLP.
Snow will take up the role of CEO at Sensyne Health once this funding has been completed, which is expected to be within ten days.